Testing effectiveness (Phase 2)Looking for participantsNCT03667170What this trial is testingKN035 for dMMR/MSI-H Advanced Solid TumorsWho this might be right forSolid Tumor 3D Medicines (Sichuan) Co., Ltd. 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03935893What this trial is testingAdoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersWho this might be right forGastric CancerColorectal CancerPancreatic Cancer+7 more Udai Kammula 20
Testing effectiveness (Phase 2)WithdrawnNCT04001101What this trial is testingAnti-PD-1 +/- RT for MSI-H Solid TumorsWho this might be right forMicrosatellite Instability HighMismatch Repair DeficiencyColorectal Cancer University of Colorado, Denver
Testing effectiveness (Phase 2)Active Not RecruitingNCT07523763What this trial is testingNeoadjuvant Low-dose Immunotherapy in Locally Advanced MMR-deficient Colorectal CancerWho this might be right forColorectal Cancer (MSI-H)Colorectal Cancer (CRC) Blokhin's Russian Cancer Research Center 30
Testing effectiveness (Phase 2)UnknownNCT04118933What this trial is testingPD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal CancerWho this might be right forColorectal Cancer Xu jianmin 40
Early research (Phase 1)Ended earlyNCT05909995What this trial is testingInterventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid TumorsWho this might be right forMelanomaHepatocellular Carcinoma (HCC)Renal Cell Carcinoma (RCC)+3 more Incyte Corporation 8
Testing effectiveness (Phase 2)Looking for participantsNCT06002789What this trial is testingSafety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCCWho this might be right forMultiple CancerColorectal Cancer Sixth Affiliated Hospital, Sun Yat-sen University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT02628067What this trial is testingStudy of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)Who this might be right forAdvanced CancerAnal CarcinomaAnal Cancer+22 more Merck Sharp & Dohme LLC 1,609
Not applicableEnded earlyNCT04106167What this trial is testingLong-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyWho this might be right forAdvanced Solid TumorLymphomaGastric Cancer+15 more Fate Therapeutics 20
Large-scale testing (Phase 3)Active Not RecruitingNCT02997228What this trial is testingTesting the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT StudyWho this might be right forMetastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v7 National Cancer Institute (NCI) 120
Not applicableActive Not RecruitingNCT05511688What this trial is testingNational Cohort of Colorectal Cancers With Microsatellite InstabilityWho this might be right forColorectal CancerMicrosatellite Instability Federation Francophone de Cancerologie Digestive 637
Testing effectiveness (Phase 2)Active Not RecruitingNCT04895722What this trial is testingEvaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008)Who this might be right forColorectal Cancer Merck Sharp & Dohme LLC 302
Not applicableUnknownNCT00172757What this trial is testingAssociation of Colorectal Cancer With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations in TaiwanWho this might be right forColorectal Cancer National Taiwan University Hospital 1,000
Not applicableStudy completedNCT06238193What this trial is testingMolecular Characteristics of Early-onset Compared With Late-onset Colorectal CancerWho this might be right forColorectal CancerMicrosatellite Instability The First Affiliated Hospital with Nanjing Medical University 11,344
Not applicableStudy completedNCT03047226What this trial is testingDiagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal CancerWho this might be right forLynch Syndrome Second Affiliated Hospital, School of Medicine, Zhejiang University 311
Not applicableLooking for participantsNCT06353854What this trial is testingProspective National Cohort Evaluating Predictive Biomarkers of Resistance to Immunotherapy in Patients With MSI/dMMR Metastatic Colorectal Cancer (CORESIM)Who this might be right forColorectal Cancer MetastaticMicrosatellite Instability-High Colorectal Cancer Federation Francophone de Cancerologie Digestive 600
Early research (Phase 1)Looking for participantsNCT06004245What this trial is testingEvaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsColorectal Cancer Vividion Therapeutics, Inc. 280
Testing effectiveness (Phase 2)Study completedNCT01876511What this trial is testingStudy of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C)Who this might be right forMSI Positive Colorectal CancerMSI Negative Colorectal CancerMSI Positive Non-Colorectal Cancers Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 113
Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT03241173What this trial is testingA Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic MalignanciesWho this might be right forAdvanced Malignancies Incyte Biosciences International Sàrl 52